Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative Conditioning with Busulfan, Fludarabine, and ATG for Unrelated Donor SCT
NCT00627666Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Jan 2003
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, fludarabine, antithymocyte globulin rabbit in hematologic malignancy, acute leukemia, chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS), sponsored by Asan Medical Center. Started Jan 2003; status: completed.
02
Drugs
busulfanfludarabineantithymocyte globulin rabbit
03
Conditions
hematologic malignancyacute leukemiachronic myeloid leukemia (CML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00627666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627666.